Kathleen Kahler Fonda

Array ( [id] => 20536824 [patent_doc_number] => 12553895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => Fusion antigen of porcine Getah virus, kit, preparation method therefor and application thereof [patent_app_type] => utility [patent_app_number] => 19/246586 [patent_app_country] => US [patent_app_date] => 2025-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 0 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19246586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20213600 [patent_doc_number] => 12410242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => C-based single domain antibody for neutralizing respiratory syncytial virus and application thereof [patent_app_type] => utility [patent_app_number] => 18/777836 [patent_app_country] => US [patent_app_date] => 2024-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 15 [patent_no_of_words] => 0 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784261 [patent_doc_number] => 20250057940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/752524 [patent_app_country] => US [patent_app_date] => 2024-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13084 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18752524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19379396 [patent_doc_number] => 20240269266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => BROAD-SPECTRUM MULTI-ANTIGEN PAN-CORONAVIRUS VACCINE [patent_app_type] => utility [patent_app_number] => 18/601925 [patent_app_country] => US [patent_app_date] => 2024-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34919 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18601925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19638205 [patent_doc_number] => 12168807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-17 [patent_title] => Multiplexed nucleic acid detection kit for human papilloma virus (HPV) typing, and detection method [patent_app_type] => utility [patent_app_number] => 18/512036 [patent_app_country] => US [patent_app_date] => 2023-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7975 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19682427 [patent_doc_number] => 20250000972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => INTRANASAL VACCINE COMPOSITION AND METHOD FOR BOOSTING USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/374118 [patent_app_country] => US [patent_app_date] => 2023-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6691 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18374118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19096377 [patent_doc_number] => 20240115604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => METHODS OF MANUFACTURING GENETICALLY-MODIFIED LYMPHOCYTES [patent_app_type] => utility [patent_app_number] => 18/227747 [patent_app_country] => US [patent_app_date] => 2023-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18227747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18939862 [patent_doc_number] => 20240035001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => BACTERIOPHAGE INFECTING DIABETES-INDUCING BACTERIUM AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/356448 [patent_app_country] => US [patent_app_date] => 2023-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13459 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18356448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18727116 [patent_doc_number] => 20230341397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => PROTEASE BIOSENSORS AND METHODS OF VIRUS DETECTION [patent_app_type] => utility [patent_app_number] => 18/182030 [patent_app_country] => US [patent_app_date] => 2023-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15718 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18754016 [patent_doc_number] => 20230357382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 18/158273 [patent_app_country] => US [patent_app_date] => 2023-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18418602 [patent_doc_number] => 20230173060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => LARGE SEQUENCE PAN-CORONAVIRUS VACCINE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/046875 [patent_app_country] => US [patent_app_date] => 2022-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18365341 [patent_doc_number] => 20230146932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => MULTI-EPITOPE PAN-CORONAVIRUS VACCINE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/046862 [patent_app_country] => US [patent_app_date] => 2022-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43329 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18510074 [patent_doc_number] => 20230226173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => PAN-CORONAVIRUS VACCINE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/046462 [patent_app_country] => US [patent_app_date] => 2022-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33192 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19404918 [patent_doc_number] => 20240288429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => ANTIBODY AGAINST NUCLEOCAPSID PROTEIN OF SARS-COV-2 [patent_app_type] => utility [patent_app_number] => 18/572224 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20116187 [patent_doc_number] => 12365879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Synthetic chimeric poxviruses [patent_app_type] => utility [patent_app_number] => 17/827320 [patent_app_country] => US [patent_app_date] => 2022-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 23400 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17827320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18037564 [patent_doc_number] => 20220381780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => VIRAL STRAIN SEROLOGY ASSAYS [patent_app_type] => utility [patent_app_number] => 17/749721 [patent_app_country] => US [patent_app_date] => 2022-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 100256 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 683 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17749721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19345240 [patent_doc_number] => 20240254203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => ANTIBODY-BASED ANTIVIRUS COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/560621 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60340 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -90 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18311357 [patent_doc_number] => 20230115257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => SARS-COV-2 SPIKE PROTEIN ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/746859 [patent_app_country] => US [patent_app_date] => 2022-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29292 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17746859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18019099 [patent_doc_number] => 20220370598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => Vaccines Against Coronavirus and Methods of Use [patent_app_type] => utility [patent_app_number] => 17/662141 [patent_app_country] => US [patent_app_date] => 2022-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17988905 [patent_doc_number] => 20220354942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => ATTENUATING VIRAL MUTATIONS IN PROTEIN GENES [patent_app_type] => utility [patent_app_number] => 17/737991 [patent_app_country] => US [patent_app_date] => 2022-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30857 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737991 [rel_patent_id] =>[rel_patent_doc_number] =>)